Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
ඕනම රටකට සෙට් වෙන CV එකක්
ErMurazor
Updated:
Today at 9:50 AM
Hambantota
7 Acres Beachfront Land For Sell DownSouth , PerPerch Price 420 000
1024 Digital
Updated:
Wednesday at 11:57 AM
Baseus PI LITE INDOOR CAMERA
ErMurazor
Updated:
Monday at 12:26 PM
Ad icon
Colombo
Hard Disk For Sale
mazza
Updated:
Oct 10, 2026
land for sale
justasking
Updated:
Oct 10, 2026
Electronics
Vehicles
Property
Search
Reply to thread
Forums
General
ElaKiri Talk!
New Drug Extends Lifespan by 25% in Mice.
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 29973824" data-attributes="member: 562115"><p> <ul> <li data-xf-list-type="ul"><strong>Scientists have discovered that deactivating a protein called IL-11 can extend the healthy lifespan of mice by nearly 25%, raising the potential for similar benefits in humans.</strong></li> <li data-xf-list-type="ul"><strong>Researchers found that removing the IL-11 gene or using an anti-IL-11 antibody dramatically increased the lifespan and health of aging mice.</strong></li> <li data-xf-list-type="ul"><strong>These findings suggest that anti-IL-11 treatments could combat age-related diseases with minimal side effects, offering a promising avenue for future human trials.</strong></li> </ul><p>Researchers at the Medical Research Council Laboratory of Medical Science and Imperial College London, in collaboration with Duke-NUS Medical School, administered an anti-IL-11 antibody — a drug that inhibits IL-11’s effects — to mice that were 75 weeks old, comparable to about 55 years in humans.</p><p></p><p>The results were significant: mice treated with the anti-IL-11 drug from 75 weeks of age until their death showed a median lifespan extension of 22.5% in males and 25% in females, living an average of 155 weeks compared to 120 weeks in untreated mice.</p><p></p><p>In addition, the treatment significantly decreased cancer-related deaths in the animals and also reduced various diseases associated with fibrosis, chronic inflammation, and poor metabolism, which are typical of aging.</p><p></p><p>Importantly, only minimal side effects were observed.</p><p></p><p>Previously, scientists have suggested that IL-11 is an evolutionary hangover in humans.</p><p></p><p>While essential for limb regeneration in some animals, it is largely considered redundant in humans.</p><p></p><p>However, after the age of 55, IL-11 production increases in humans and has been linked to chronic inflammation, fibrosis in organs, metabolic disorders, muscle wasting (sarcopenia), frailty, and cardiac fibrosis — many signs of aging.</p><p></p><p>When an individual experiences two or more of these conditions, it is termed multimorbidity, encompassing a variety of ailments such as lung disease, cardiovascular disease, diabetes, and sensory decline, among others.</p><p></p><p>IL-11 gene activity increases in all mouse tissues with age, and when activated, it leads to multimorbidity, manifesting as age-related diseases and functional decline throughout the body, affecting vision, hearing, muscle strength, hair, heart function, and kidneys.</p></blockquote><p></p>
[QUOTE="imhotep, post: 29973824, member: 562115"] [LIST] [*][B]Scientists have discovered that deactivating a protein called IL-11 can extend the healthy lifespan of mice by nearly 25%, raising the potential for similar benefits in humans.[/B] [*][B]Researchers found that removing the IL-11 gene or using an anti-IL-11 antibody dramatically increased the lifespan and health of aging mice.[/B] [*][B]These findings suggest that anti-IL-11 treatments could combat age-related diseases with minimal side effects, offering a promising avenue for future human trials.[/B] [/LIST] Researchers at the Medical Research Council Laboratory of Medical Science and Imperial College London, in collaboration with Duke-NUS Medical School, administered an anti-IL-11 antibody — a drug that inhibits IL-11’s effects — to mice that were 75 weeks old, comparable to about 55 years in humans. The results were significant: mice treated with the anti-IL-11 drug from 75 weeks of age until their death showed a median lifespan extension of 22.5% in males and 25% in females, living an average of 155 weeks compared to 120 weeks in untreated mice. In addition, the treatment significantly decreased cancer-related deaths in the animals and also reduced various diseases associated with fibrosis, chronic inflammation, and poor metabolism, which are typical of aging. Importantly, only minimal side effects were observed. Previously, scientists have suggested that IL-11 is an evolutionary hangover in humans. While essential for limb regeneration in some animals, it is largely considered redundant in humans. However, after the age of 55, IL-11 production increases in humans and has been linked to chronic inflammation, fibrosis in organs, metabolic disorders, muscle wasting (sarcopenia), frailty, and cardiac fibrosis — many signs of aging. When an individual experiences two or more of these conditions, it is termed multimorbidity, encompassing a variety of ailments such as lung disease, cardiovascular disease, diabetes, and sensory decline, among others. IL-11 gene activity increases in all mouse tissues with age, and when activated, it leads to multimorbidity, manifesting as age-related diseases and functional decline throughout the body, affecting vision, hearing, muscle strength, hair, heart function, and kidneys. [/QUOTE]
Insert quotes…
Verification
Winadiyakata thappara keeyak tibeda?
Post reply
Top
Bottom